Unchained Labs revs up its gene therapy engine, acquires NanoView Biosciences!

May 4, 2022 – Pleasanton, CA – Unchained Labs, the life sciences company that’s all about getting biologics and gene therapy researchers the right tools for the job, acquired NanoView Biosciences today. NanoView’s ExoView technology sits in pole position for characterizing exosomes and their recently launched LentiView platform is a game-changer for gene therapy researchers…

Read More

Unagi is a state of total awareness…and Unchained Labs’ new benchtop buffer exchange platform!

April 5, 2022 – Pleasanton, CA – Unchained Labs, the life sciences company that’s all about getting biologics and gene therapy researchers the right tools for the job, launched Unagi today – the only hands-free benchtop buffer exchange platform that completely liberates researchers from this mind-numbing yet mission critical step in their process. Buffer exchange…

Read More

Unchained Labs adds biopharma vet Laura Hamill to the Board

February 9, 2022 – Pleasanton, CA – Unchained Labs, the life sciences company that’s all about getting biologics and gene therapy researchers the right tools for the job, announced the addition of Laura Hamill to its Board today. Laura has more than three decades of experience in the biopharma industry, most recently as EVP Worldwide…

Read More

Unchained Labs blasts Big Kahuna and Junior into the future, launches LEA 10!

October 19, 2021 – Pleasanton, CA – Unchained Labs, the life sciences company that’s all about getting biologics and gene therapy researchers the right tools for the job, released its LEA 10 automation software today – making Big Kahuna and Junior even more ready to plow through scientific challenges and workflow bottlenecks. Big Kahuna and Junior…

Read More

Unchained Labs stocks up on dry powder with $155M debt facility

August 10, 2021 – Pleasanton, CA – Unchained Labs, the life sciences company that’s all about getting biologics and gene therapy researchers the right tools for the job, today announced that it has closed a $155M debt facility with Midcap Financial and Golub Capital to support future acquisitions. The debt facilities include a revolver, a…

Read More

Unchained Labs does it again for gene therapy and vaccine researchers, adds nanoparticle suite to Stunner

July 1, 2021 – Pleasanton, CA – Unchained Labs, the life sciences company that’s all about getting biologics and gene therapy researchers the right tools for the job, launched a new application suite for the characterization of nanoparticles on Stunner today. Stunner is already the go-to solution for AAV titer and empty/full ratio measurements, and…

Read More

The Carlyle Group to acquire rapidly growing life sciences tools company Unchained Labs

April 26, 2021 – Pleasanton, CA – Global investment firm The Carlyle Group (NASDAQ:CG) today announced that it has agreed to acquire the rapidly growing life sciences tools company Unchained Labs for $435 million, in partnership with its management team, from Novo Holdings A/S, Canaan Partners and TPG Biotech. The transaction is subject to regulatory…

Read More

Unchained Labs sticks it to viruses, launches new mRNA vaccine application on Stunner!

January 11, 2021 – Pleasanton, CA – Unchained Labs, the life sciences company that’s all about getting researchers the right tool for the job, launched its new mRNA vaccine application on Stunner today. Stunner is the only platform that can simultaneously quantify the total amount of mRNA and measure the size distribution of lipid nanoparticles –…

Read More

Unchained Labs launches the ultimate gene therapy tool; tackle AAV titer, empty/full ratio and more with Stunner!

October 6, 2020 – Pleasanton, CA – Unchained Labs, the life sciences company that’s all about getting researchers the right tool for the job, launched its new gene therapy quantification application on Stunner today. Stunner is the first platform that gives researchers a full read-out on how many AAV capsids they have, how many are…

Read More